top of page

German Officials Under Pressure To Unveil Marijuana Legalization’s Second Step Focused On Commercial Sales

  • Writer: Bob Marley
    Bob Marley
  • Apr 5, 2024
  • 3 min read

Now that marijuana is legal in Germany, lawmakers are turning their attention to the planned “second pillar” of the reform: establishing a pilot program for commercial sales. And while the timeline for introducing the complementary legislation is unclear, one key lawmaker says she’s hoping to see a draft emerge this summer.

Cannabis possession and cultivation for personal officially became legal on Monday, and social clubs where people could become members and obtain marijuana are due to launch in July. But so far, there are no definitive details about what the broader commercial pilot program could look like.

“Preparatory work on the second pillar of the cannabis laws is currently underway with the departments involved,” the Federal Ministry of Health (BMG) told Tagesspiegel Background. But specifics about the plan “cannot be given at the moment.”

Health Minister Karl Lauterbach, who has spearheaded the government’s cannabis legalization efforts, told members of the Bundestag in December that “we are currently examining” the commercial sales legislation. But with legalization now in effect, there’s increased pressure to expedite that process.

Kristine Lütke of the Free Democratic Party (FDP) said that, while the first phase of reform represents “a paradigm shift towards a liberal drug policy,” she’s “convinced” of the need to establish a commercial program.

“I am counting on Karl Lauterbach’s commitment to address pillar two of cannabis legalization promptly and to present a corresponding draft,” she said.

Ich zähle auf die Zusage von Karl Lauterbach, auch Säule Zwei der Cannabis-Legalisierung zeitnah anzugehen und einen entsprechenden Entwurf vorzulegen. https://t.co/cAge10tNQs

— Kristine Lütke MdB (@kristine_lutke) April 4, 2024


Lütke also recognized that the follow-up sales legislation could face stronger resistance in the Bundesrat representing individual states. Because dispensaries would be more visible and involve more complex policy considerations, the future legislation will likely be exposed to additional criticism and possible pushback.

The Bundesrat previously tried to block the now-enacted legalization proposal last September but ultimately failed.

Despite that, members of the Bundesrat ultimately reached a deal with Lauterbach and other government ministers and declined to refer the cannabis legislation to a mediation committee that would have delayed implementation by six months.

Kirsten Kappert-Gonther of the Green party said she agrees that the “second pillar is important in order to minimize the health risk for occasional users and to create alternatives to the black market.”

She added that “the legal framework conditions should be determined promptly.”

“It would be good if the BMG managed to present a draft law in the summer so that the states and other actors can be intensively involved in the consultation process,” she said. “This concern can be addressed with a legal basis for specialist shops.”

The commercial legalization legislation is also expected to be unveiled after its submitted to the European Commission for review.

While Germany’s Federal Cabinet approved the initial framework for a legalization measure in late 2022, the government also said it wanted to get signoff from the EU to ensure that enacting the reform wouldn’t put them in violation of their international obligations.

Marijuana Moment is tracking more than 1,400 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

Officials took a first step toward legalization in 2022, kicking off a series of hearings meant to help inform legislation to end prohibition in the country.

Government officials from multiple countries, including the U.S., also met in Germany last November to discuss international marijuana policy issues as the host nation works to enact legalization.

A group of German lawmakers, as well as Narcotics Drugs Commissioner Burkhard Blienert, separately visited the U.S. and toured California cannabis businesses in 2022 to inform their country’s approach to legalization.

The visit came after top officials from Germany, Luxembourg, Malta and the Netherlands held a first-of-its-kind meeting to discuss plans and challenges associated with recreational marijuana legalization.

Leaders of the coalition government said in 2021 that they had reached an agreement to end cannabis prohibition and enact regulations for a legal industry, and they first previewed certain details of that plan last year.

A novel international survey that was released in 2022 found majority support for legalization in several key European countries, including Germany.

Meanwhile, the United Nations’s (UN) drug control body recently reiterated that it considers legalizing marijuana for non-medical or scientific purposes a violation of international treaties, though it also said it appreciates that Germany’s government scaled back its cannabis plan ahead of the recent vote.

Schumer Says Passing Marijuana Banking Bill Is Part Of The Senate’s ‘Busy Agenda’ In The ‘Weeks And Months Ahead’

Recent Posts

See All

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page